Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


ICML 2017: Highlights

Written by | 30 Jul 2017 | All Medical News

Interviewer: Esther Drain

Dr Toby Eyre (Oxford),  Professor Anas Younes (MSKCC, USA), Dr Andrew Davies (Southampton) and Dr Graham Collins (Oxford) discuss new data in CAR T cell therapy and the first EZH2 inhibitor, tazemetostat, in the management of follicular lymphoma as their highlights at ICML.

Professor John Radford (Manchester), Professor Peter Johnson (Southampton) and Professor Stephen Ansell (Mayo Clinic, USA) highlight data from Rathl, emerging data on circulating tumour DNA and a general round up of the meeting.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.